Tandem (TNDM) stock was upgraded, and Zimmer (ZBH) stock and ResMed (RMD) stock were downgraded as part of Baird's 2026 ...
The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback